Hydrazide Based HDAC3 Selective Inhibitors
Inventors:
Prof. Balaram Ghosh , Swati Biswas, Routholla Ganesh, Pulya Sravani, Tarun Patel
Existing embodiments may limit the scope of inventive applications, suggesting a need for further innovation in histone deacetylase 3 inhibitors.
The invention provides potent, selective HDAC3 inhibitors with a novel benzoylhydrazide scaffold and a simplified synthesis process, enhancing drug development efficiency
This invention introduces a compound selectively inhibiting HDAC enzymes, with a unique structure for enhanced HDAC3 specificity and a streamlined synthesis, offering significant advancements in therapeutic applications and manufacturing efficiency.
Potential Indian Clients: Pharmaceutical companies involved in cancer research and drug development, research institutions focusing on cancer therapeutics
Current TRL: NA
Funded by: NA
IPC: C07D
Domain: Chemistry, Pharmaceutical Sciences
This website uses cookies or similar technologies, to enhance your browsing experience.